The increasing prevalence of human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) and surging healthcare expenditure on HIV and related activities are two of the key factors responsible for the growth of the HIV diagnosis market. During the forecast period (2017–2023), the market is predicted to advance at a CAGR of 10.6%. HIV diagnosis refers to the tests performed to detect the presence of HIV in human blood. HIV weakens the immune system and leads to AIDS, if not treated timely. Browse Report Description at: [URL=https://www.psmarketresearch.com/]https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market[/URL]
Of these, during 2013–2016, assays, kits & reagents led the market in terms of revenue, and these are expected to maintain their lead during 2017–2023, owing to the growing adoption of reagents in home as well as laboratory HIV tests. On the basis of end user, the HIV diagnosis market is broadly classified into research institutes, diagnostic laboratories, and hospitals. Among these, during the historical period, diagnostic laboratories witnessed the fastest growth in the market, and these are projected to exhibit similar growth during the forecast period.
Download Report Sample at:
[FURL]https://www.psmarketresearch.com/market-analysis/hiv-diagnosis-market/report-sample[/FURL]
This is attributed to the fact that the majority of HIV tests are performed at laboratories. In addition, these laboratories provide the benefit of the latest instruments along with skilled professionals who can conduct various tests to confirm the diagnosis of HIV infection. As per the Joint United Nations Programme on HIV/AIDS (UNAIDS), the incidence of HIV/AIDS surged by 2.8 million from 2011 to 2015, and around 36.7 million people tested positive for HIV across the globe. In 2015, approximately 40.0% of the people suffering from HIV were not aware of their status.
As per UNAIDS, in 2016, low and middle-income nations spent $19.0 billion on AIDS and HIV-related activities in 2015, of which 57.0% came from their domestic budgets. Taking into account the rising incidence of HIV cases, UNAIDS estimated that around $26.2 billion will be needed to respond to the epidemic of HIV infection in 2020 and nearly $23.9 billion for the same purpose in 2030. The overall healthcare expenditure on HIV and related activities is expected to augment the HIV diagnosis market growth.
Hence, the growing incidence of HIV/AIDS and significant healthcare expenditure on diagnosis and related activities are being witnessed as the major growth drivers of the market.